A 2026 study published in BMC Medicine, “Integration of gut microbiome and lipid metabolism reveals the anti-cancer effects ...

Integrating proteomics with systems biology reveals complex cellular networks, improving disease mechanisms understanding and precision medicine applications.

Cue Biopharma, Inc. ( CUE) Discusses CUE-401 R&D Progress and Mechanism for Autoimmune and Inflammatory Diseases April 7, 2026 10:00 AM EDT Lucinda Warren - Interim CEO, Interim President,Principal ...

Macrophages, the immune system’s front-line scavenger cells, do more than simply digest dead cells. A new study published in ...

Leucine-rich repeat kinase 2 (LRRK2) has emerged as a critical player in both neurological and peripheral diseases. In a ...

What is the TREM-1 receptor? A new review explores TREM-1's role in sepsis, rheumatoid arthritis, and neuroinflammation.

What consumers searching for a natural GLP-1 supplement should know about Bioma GLP-1 Booster's Akkermansia muciniphila and ...

A 2026 informational consumer evaluation of Nitric Boost Ultra's nitric oxide formulation claims, circulation support ...

Q4 2025 Earnings Call March 25, 2026 4:30 PM EDTCompany ParticipantsMichael Handley - CEO & DirectorLisa Wolf - ...

Successful transformation to global biotech platform with two mid-stage potential best-in-class/first-in-class programs, givastomig and VIS-101, with compelling proof-of-concept dataGivastomig, a pote ...

Net loss attributable to NovaBridge was $46.3 million for the year ended December 31, 2025, compared to $22.2 million for the year ended December 31, 2024. Net loss per share attributable to ordinary ...

A Chinese-language research paper on laser-induced damage to spacecraft solar arrays has drawn fresh attention to the ...